25 April 2019

Harry Dolstra, theme Cancer development and immune defense, is elected as new executive board member and treasurer of the European Society for Blood and Marrow Transplantation (EBMT)

We congratulate Harry Dolstra with this election as new board member of the EBMT. 

The EBMT has more than 4,000 members in over 60 countries, and is a collaborative peer network of professionals working, in centers and as individuals, in the field of clinical stem cell transplantation and cellular therapy. Members contribute to and benefit from the collective knowledge that the EBMT has accrued, with the ultimate goal of saving the lives of patients with blood cancers and other life-threatening diseases. The EBMT has a governing body, the Board of Association, and two sets of groups that channel the society's research aims and other activities: the Working Parties and the EBMT Committees.

The EBMT is devoted to the promotion of all knowledge associated with the transplantation of hematopoietic stem cells from all donor sources and donor types including basic and clinical research, education, standardization, quality control, and accreditation for transplant procedures. The mission is to save the lives of patients with blood cancers and other life-threatening diseases by advancing the fields of blood and marrow transplantation and cell therapy worldwide through science, education and advocacy. 


 

Related news items


Cognitive behavioral therapy reduces severe fatigue in patients with advanced cancer during treatment

23 January 2020

In Annals of Oncology, RIHS researchers Hanneke Poort, Marlies Peters, Winette van der Graaf, Ria Nijhuis van der Sanden and colleagues showed significant effects of cognitive behavioral therapy on fatigue in patients with advanced cancer during treatment with palliative intent.

read more

6 million euros to uncover link between metabolic and brain disorders

21 January 2020

An important European-funded initiative, coordinated by Radboudumc researchers Barbara Franke, Jan Buitelaar, and Janita Bralten, has been launched to explore how common molecular mechanisms may link metabolic disorders with brain disorders.

read more

NWO Open Competition Domain Science - XS grant for Ronald van Rij and Jenny van der Wijst

21 January 2020

NWO Domain Science has awarded Ronald van Rij, theme Infectious diseases and global health and Jennny van der Wijst, theme Renal disorders an XS grant. The XS category emphatically strives to encourage curiosity-driven and bold research involving a relatively quick analysis of a promising idea.

read more

First BeNeFit funding granted for psoriasis

17 January 2020

RIHS researchers Elke de Jong and Juul van den Reek of Dermatology Radboudumc and Dermatology Ghent received a grant of 1.6 million euros for investigating dose reduction of the newest biologics for psoriasis.

read more

RIMLS award ceremony proudly presenting the winners

16 January 2020

Several RIMLS researchers received an award and bonus during the New Year's drinks. See all photo's and the ENABLE aftermovie.

read more

Stofwisselkracht grant for Daan Panneman and Richard Rodenburg

16 January 2020

Daan Panneman & Richard Rodenburg have been awarded a Stofwisselkracht grant for their proposal “CRISPR/Cas9 knock-in complementation in fibroblasts of mitochondrial disease patients”. Together with Omar Tutakhel & Jan Smeitink they will investigate the possibility of using CRISPR/Cas9 knock-in.

read more